N-(3-(1H-Imidazol-1-yl)propyl)-N-(5,7-dimethylbenzo[d]thiazol-2-yl)-2,3-dihydrobenzo[b][1,4]dioxine-2-carboxamide hydrochloride

Catalog No. :
ACSBAV141
CAS No. :
1217033-58-3
Molecular Formula :
C24H25ClN4O3S
Molecular Weight :
485.01

IUPAC Name:N-(3-(1H-imidazol-1-yl)propyl)-N-(5,7-dimethylbenzo[d]thiazol-2-yl)-2,3-dihydrobenzo[b][1,4]dioxine-2-carboxamide hydrochloride

N-(3-(1H-Imidazol-1-yl)propyl)-N-(5,7-dimethylbenzo[d]thiazol-2-yl)-2,3-dihydrobenzo[b][1,4]dioxine-2-carboxamide hydrochloride structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
No pack options available.

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product NameN-(3-(1H-Imidazol-1-yl)propyl)-N-(5,7-dimethylbenzo[d]thiazol-2-yl)-2,3-dihydrobenzo[b][1,4]dioxine-2-carboxamide hydrochloride
IUPAC NameN-(3-(1H-imidazol-1-yl)propyl)-N-(5,7-dimethylbenzo[d]thiazol-2-yl)-2,3-dihydrobenzo[b][1,4]dioxine-2-carboxamide hydrochloride
Molecular FormulaC24H25ClN4O3S
Molecular Weight485.01
SMILESO=C(C1COC2=CC=CC=C2O1)N(CCCN3C=CN=C3)C4=NC5=CC(C)=CC(C)=C5S4.[H]Cl
InChI KeyAYLQQIKJEZRFEX-UHFFFAOYSA-N
SynonymN-(5,7-dimethyl-1,3-benzothiazol-2-yl)-N-(3-imidazol-1-ylpropyl)-2,3-dihydro-1,4-benzodioxine-3-carboxamide:hydrochloride
CAS No.1217033-58-3

Synthetic Route by SureRoute

1. ACSBAV141 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACSBAV141 route product structure diagram
    ACSBAV1411217033-58-3
Inquiry

2. ACSBAV141 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACVSCI231 route compound structure diagram
    ACVSCI2313663-80-7 In Stock
  4. Then
  5. ACSBAV141 route product structure diagram
    ACSBAV1411217033-58-3
Inquiry

Comments (0)